Key facts
- The Pentagon issued new clinical guidance for a mandatory testosterone deficiency screening policy for service members aged 30 and older.
- The guidance was temporarily rescinded to allow for updates.
- Interim guidance for testosterone screening remains in effect.
- Men aged 30 and older were to undergo mandatory testosterone blood tests.
- Women were to be screened for fatigue and disrupted menstrual cycles related to hormonal issues.
- Medical experts expressed concerns regarding the scientific basis and potential for unnecessary treatment.
The Pentagon had issued new clinical guidance for a mandatory testosterone deficiency screening policy for active-duty and reserve service members aged 30 and older. The policy aimed to improve military readiness by managing hormonal and energy-availability issues. Men aged 30 and above were to undergo mandatory testosterone blood tests, while younger men would only be tested if requested or if clinicians observed warning signs. For women, the policy included screening for fatigue and disrupted menstrual cycles, which can indicate hormonal dysregulation and low-energy availability. However, the Pentagon has temporarily rescinded the guidance to allow for updates, with interim guidance remaining in effect. Medical professionals had voiced concerns that widespread testosterone testing could lead to unnecessary or harmful treatments, citing a lack of evidence that such screening improves U.S. combat readiness. The U.S. Food and Drug Administration is planning a mid-September meeting of experts to discuss the medical use of testosterone.